EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Type 1 and CD103 + Type 2 Conventional Dendritic Cells Are Decreased in Active Patients with Ulcerative Colitis but Not with Crohn's Disease

Elisa Arribas-Rodríguez iD, Carolina G de Castro iD, Aida Fiz-López iD, Ángel De Prado, Álvaro Martín-Muñoz, Luis Fernández Salazar, Jesús Barrio, Sandra Izquierdo, Javier García Alonso, Beatriz de Andrés iD, José María García-Abril, Alejandro Romero und 7 weitere

European Journal of Immunology · 2026-02 · 56 (2)

DOI: 10.1002/eji.70118 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Immunology, online erschienen am 24.02.2026. Verfasst von Elisa Arribas-Rodríguez und 18 weiteren Autor:innen. Beteiligte Einrichtung: Mucosal Immunology Lab, Instituto Biomedicina y Genética Molecular de Valladolid (IBGM, Universidad De Valladolid-CISC), Valladolid, Spain. Hauptthemen laut MEDLINE: Dendritic Cells, Integrin alpha Chains, Crohn Disease, Antigens, CD. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Spanish Ministry of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to characterize human intestinal conventional dendritic cells (cDCs) in health and inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn's disease (CD). Three cDC subsets (CD103 − cDC2, CD103 + cDC2, and cDC1) were identified from lamina propria mononuclear cells. Their phenotype and function were analyzed in healthy and IBD‐inflamed gut tissues. In the healthy gut, cDC2 predominated over cDC1, with CD103 + cDC2 dominating the duodenum and CD103 − cDC2 prevalent in the ileum and colon. CD103 + cDC2 expressed higher PD‐L1 and produced more IL‐10. In culture, CD103 + cDC2 increased proportionally unless inhibited by LPS. All subsets induced IL‐10 + helper T‐cell differentiation, with ileal cDCs being more stimulatory than colonic ones. In IBD, cDCs showed constitutively lower SIRPα expression across conditions. Notably, UC‐inflamed colon exhibited reduced cDC1 and CD103 + cDC2, while CD‐inflamed colon maintained these subsets but showed increased T‐cell stimulation and IL‐17 + T‐cell priming. Intestinal cDC subsets prime IL‐10 + helper T‐cells in health. In UC, reduced cDC1 and CD103 + cDC2 in inflamed mucosa contrast with CD, suggesting distinct pathogenic mechanisms that could inform targeted therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dendritic CellsIntegrin alpha ChainsCrohn DiseaseAntigens, CDColitis, UlcerativeHumansMaleFemaleAdultIntestinal MucosaInterleukin-10Cell DifferentiationMiddle AgedColon

Stichwörter der Autor:innen

conventional dendritic cellshumaninflammatory bowel disease

Substanzen

Integrin alpha ChainsAntigens, CDalpha E integrinsInterleukin-10

Autor:innen und Institutionen

  • Mucosal Immunology Lab, Instituto Biomedicina y Genética Molecular de Valladolid (IBGM, Universidad De Valladolid-CISC), Valladolid, Spain.
  • Servicio De Gastroenterología. Hospital Universitario Río Hortega, Valladolid, Spain.
  • Cytometry Unit. Unidad de Excelencia Instituto Biomedicina y Genética Molecular (IBGM, Universidad De Valladolid-CISC), Valladolid, Spain.
  • Servicio De Gastroenterología. Hospital Clínico Universitario, Valladolid, Spain.
  • Servicio De Cirugía General y Del Aparato Digestivo. Hospital Clínico Universitario, Valladolid, Spain.
  • Servicio De Cirugía. Hospital Universitario Río Hortega, Valladolid, Spain.

ORCID-Profile: Elisa Arribas-Rodríguez, Carolina G de Castro, Aida Fiz-López, Beatriz de Andrés, José A Garrote

Förderung

  • Spanish Ministry of Science

Zitieren

APA

Arribas-Rodríguez, E., de Castro, C. G., Fiz-López, A., De Prado, Á., Martín-Muñoz, Á., Fernández Salazar, L., Barrio, J., Izquierdo, S., García Alonso, J., de Andrés, B., García-Abril, J. M., Romero, A., Sánchez González, J., Santander, C., Arranz, E., Chaparro, M., Garrote, J. A., Gisbert, J. P., & Bernardo, D. (2026). Type 1 and CD103 + Type 2 Conventional Dendritic Cells Are Decreased in Active Patients with Ulcerative Colitis but Not with Crohn's Disease. European Journal of Immunology, 56(2). https://doi.org/10.1002/eji.70118

Vancouver

Arribas-Rodríguez E, de Castro CG, Fiz-López A, De Prado Á, Martín-Muñoz Á, Fernández Salazar L, et al. Type 1 and CD103 + Type 2 Conventional Dendritic Cells Are Decreased in Active Patients with Ulcerative Colitis but Not with Crohn's Disease. European Journal of Immunology. 2026;56(2). doi:10.1002/eji.70118

BibTeX
@article{ArribasRodrguez2026,
  author = {Arribas-Rodríguez, Elisa and de Castro, Carolina G and Fiz-López, Aida and De Prado, Ángel and Martín-Muñoz, Álvaro and Fernández Salazar, Luis and Barrio, Jesús and Izquierdo, Sandra and García Alonso, Javier and de Andrés, Beatriz and García-Abril, José María and Romero, Alejandro and Sánchez González, Javier and Santander, Cecilio and Arranz, Eduardo and Chaparro, María and Garrote, José A and Gisbert, Javier P and Bernardo, David},
  title = {Type 1 and CD103 + Type 2 Conventional Dendritic Cells Are Decreased in Active Patients with Ulcerative Colitis but Not with Crohn's Disease},
  journal = {European Journal of Immunology},
  year = {2026},
  volume = {56},
  number = {2},
  doi = {10.1002/eji.70118}
}
Kostenlos starten →